CapitaLand Unveils 14 Billion Life Sciences Hub Geneo at Science Park Bill Gates Discusses Meeting with Trump Musks DOGE and Childhood in WSJ Interview Ahead of Source Code Book Telecoms CEO Warns Europe Underestimates Risks of US Dominance in Satellites and AI Equinix Stock Outlook Wall Street Sentiment Reflects Cautious Optimism on Data Center Demand Airtel Defends Priority Postpaid Plan Before DoT Denies Net Neutrality Breach ClickUps Workforce Reduction Signals Shift in Tech Employment Trends Ernexa Therapeutics ERNA Q3 2023 Earnings Net loss of 103 per share highlights ongoing clinical investment stock declines 377 LIVN Q1 2026 Earnings EPS Beats Estimates by 714 Stock Declines Slightly NRG Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher TLPH Q1 2026 Earnings Significant EPS Beat as PreRevenue Biotech Advances Pipeline COYA Q1 2026 Earnings NarrowerthanExpected Loss as Biotech Advances Pipeline HCXY Q1 2026 Earnings Slight EPS Miss Amid Stable Operations Unity Software Holds Steady Near 2557 as Market Weighs Support and Resistance Capital Southwest Corporation CSWC Slips as Key Support Levels Loom Costamare Bulkers Holdings CMDB Slips 089 as Shares Test Key Support Zone Ready Capital Notes RCB Hover Near Par as Modest Moves Signal Stability Carlyle Credit Income Fund Series D Preferred Shares CCID Hold Steady at 2535 Berkshire Hathaway Reenters Airlines with 26 Billion Delta Air Lines Stake Corteva Q1 2026 Earnings Strong Earnings Beat Driven by Operational Efficiency McKinley Acquisition Corporation Rights MKLYR Surges 40 Rights Trading at 014 VBNK Q1 2026 Earnings EPS Misses Estimates as Operating Headwinds Materialize CNP Q1 2026 Earnings Narrow EPS Miss Modest Stock Uptick Amid Utility Stability KRNY Q1 2026 Earnings Slight EPS Miss Weighs on Shares After Mixed Quarter Applied Industrial Technologies AIT Q1 2026 Earnings Slight EPS Miss as Margins Face Pressure Transcat TRNS Q1 2026 Earnings EPS Misses Estimates as Stock Gains 314 CubeSmart Q1 2026 Earnings EPS Beats Estimates by 141 Stock Slips Slightly BioLineRx Ltd BLRX Q3 2024 Earnings Narrowed Losses and Pipeline Progress Amidst Low Revenue